Mednax Net Income Applicable To Common Shares from 2010 to 2026
| MD Stock | USD 19.85 0.01 0.05% |
Net Income Applicable To Common Shares | First Reported 2000-03-31 | Previous Quarter 71.7 M | Current Value 33.7 M | Quarterly Volatility 151.8 M |
Check Mednax financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mednax's main balance sheet or income statement drivers, such as Depreciation And Amortization of 29.7 M, Interest Expense of 25.7 M or Total Revenue of 1.5 B, as well as many indicators such as Price To Sales Ratio of 0.91, Dividend Yield of 0.0 or PTB Ratio of 3.38. Mednax financial statements analysis is a perfect complement when working with Mednax Valuation or Volatility modules.
Mednax | Net Income Applicable To Common Shares | Build AI portfolio with Mednax Stock |
Analyzing Mednax's Net Income Applicable To Common Shares over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income Applicable To Common Shares has evolved provides context for assessing Mednax's current valuation and future prospects.
Latest Mednax's Net Income Applicable To Common Shares Growth Pattern
Below is the plot of the Net Income Applicable To Common Shares of Mednax Inc over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. Mednax's Net Income Applicable To Common Shares historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mednax's overall financial position and show how it may be relating to other accounts over time.
| Net Income Applicable To Common Shares | 10 Years Trend |
|
Net Income Applicable To Common Shares |
| Timeline |
Mednax Net Income Applicable To Common Shares Regression Statistics
| Arithmetic Mean | 23,564,729 | |
| Geometric Mean | 195,105,988 | |
| Coefficient Of Variation | 2,024 | |
| Mean Deviation | 301,235,841 | |
| Median | 173,657,400 | |
| Standard Deviation | 476,911,073 | |
| Sample Variance | 227444.2T | |
| Range | 1.8B | |
| R-Value | (0.22) | |
| Mean Square Error | 230823.5T | |
| R-Squared | 0.05 | |
| Significance | 0.40 | |
| Slope | (20,813,977) | |
| Total Sum of Squares | 3639106.7T |
Mednax Net Income Applicable To Common Shares History
About Mednax Financial Statements
Mednax stakeholders use historical fundamental indicators, such as Mednax's Net Income Applicable To Common Shares, to determine how well the company is positioned to perform in the future. Although Mednax investors may analyze each financial statement separately, they are all interrelated. For example, changes in Mednax's assets and liabilities are reflected in the revenues and expenses on Mednax's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Mednax Inc. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Income Applicable To Common Shares | 165.4 M | 173.7 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out the analysis of Mednax Correlation against competitors. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Will Health Care Providers & Services sector continue expanding? Could Mednax diversify its offerings? Factors like these will boost the valuation of Mednax. Expected growth trajectory for Mednax significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Mednax data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.114 | Earnings Share 1.91 | Revenue Per Share | Quarterly Revenue Growth (0.02) | Return On Assets |
Understanding Mednax Inc requires distinguishing between market price and book value, where the latter reflects Mednax's accounting equity. The concept of intrinsic value - what Mednax's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Mednax's price substantially above or below its fundamental value.
Understanding that Mednax's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Mednax represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Mednax's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.